KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
+34.89%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$135M
AUM Growth
+$135M
(+24%)
Cap. Flow
-$1.71M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
91.35%
Holding
24
New
1
Increased
4
Reduced
1
Closed
6
Top Buys
| 1 |
Exicure
XCUR
|
$3.65M |
| 2 |
Entera Bio
ENTX
|
$2.62M |
| 3 |
Abeona Therapeutics
ABEO
|
$1.63M |
| 4 |
Corbus Pharmaceuticals
CRBP
|
$328K |
| 5 |
Aldeyra Therapeutics
ALDX
|
$220K |
Top Sells
| 1 |
Krystal Biotech
KRYS
|
$4.17M |
| 2 |
Altria Group
MO
|
$3.68M |
| 3 |
DuPont de Nemours
DD
|
$963K |
| 4 |
Galmed Pharmaceuticals
GLMD
|
$696K |
| 5 |
electroCore
ECOR
|
$481K |
Sector Composition
| 1 | Healthcare | 86.67% |
| 2 | Financials | 6.29% |
| 3 | Materials | 2.58% |
| 4 | Communication Services | 2.15% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $46.6M | 34.43% | 857,494 | – | – |
|
|
2
Corbus Pharmaceuticals
CRBP
$115M
| $27.6M | 20.34% | 5,045,870 +60,000 | +1% | +$328K |
|
3
Applied Therapeutics
APLT
$71M
| $12.7M | 9.41% | 467,071 | – | – |
|
|
4
Abeona Therapeutics
ABEO
$350M
| $9.35M | 6.9% | 2,859,767 +500,000 | +21% | +$1.63M |
|
5
Blackstone
BX
$134B
| $8.52M | 6.29% | 153,000 | – | – |
|
|
EIGR
6
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $5.22M | 3.85% | 350,238 | – | – |
|
|
7
Exicure
XCUR
$35.4M
| $3.65M | 2.7% | +1,277,777 | New | +$3.65M |
|
|
8
Entera Bio
ENTX
$88.1M
| $3.61M | 2.66% | 1,741,363 +1,265,823 | +266% | +$2.62M |
|
|
9
Aldeyra Therapeutics
ALDX
$351M
| $3.31M | 2.44% | 569,405 +37,837 | +7% | +$220K |
|
10
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$220M
| $3.14M | 2.32% | 96,000 | – | – |
|
11
Lumen
LUMN
$5.1B
| $2.91M | 2.15% | 220,000 | – | – |
|
12
Anavex Life Sciences
AVXL
$828M
| $1.88M | 1.39% | 724,205 | – | – |
|
13
Dow Inc
DOW
$17.5B
| $1.64M | 1.21% | 30,000 | – | – |
|
|
MTEM
14
DELISTED
Molecular Templates, Inc.
MTEM
| $1.59M | 1.18% | 113,905 | – | – |
|
15
Soligenix
SNGX
$10.1M
| $1.14M | 0.84% | 787,830 | – | – |
|
|
16
DuPont de Nemours
DD
$32.2B
| $963K | 0.71% | 15,000 -15,000 | -50% | -$963K |
|
17
Corteva
CTVA
$50.4B
| $887K | 0.66% | 30,000 | – | – |
|
|
OTRK
18
DELISTED
Ontrak
OTRK
| $702K | 0.52% | 43,034 | – | – |
|
|
19
electroCore
ECOR
$40.3M
| – | – | -219,844 | Closed | -$481K |
|
|
20
Galmed Pharmaceuticals
GLMD
$6.96M
| – | – | -145,694 | Closed | -$696K |
|
|
21
Krystal Biotech
KRYS
$4.27B
| – | – | -120,212 | Closed | -$4.17M |
|
|
22
Altria Group
MO
$113B
| – | – | -90,000 | Closed | -$3.68M |
|
|
NTBL
23
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| – | – | -21,400 | Closed | -$29K |
|
24
Lipocine
LPCN
$15.8M
| – | – | -50,000 | Closed | -$141K |
|